The breast cancer, gastric cancer, and nonsmall cell lung cancer patients with high expression of NCOA3 have significantly shorter overall survival times, indicating that NCOA3 may be an indicator of poor prognosis (Cai et al., 2010; Sakakura et al., 2000; Zhao et al., 2003). This evidence concerns the gene NCOA3 and gastric cancer.